Literature DB >> 12680709

Histologic analysis of liver tissue following hepatic arterial infusion of ferromagnetic particles in a rabbit tumour model.

Paul Moroz1, Cecily Metcalf, Bruce N Gray.   

Abstract

It is possible to arterially embolize liver tumours in small animal models with ferromagnetic particles that generate hysteretic heating on exposure to an alternating magnetic field. The aim of this study was to determine the response of hepatic tissue to arterial infusion of ferromagnetic particles. Eight rabbits containing hepatic VX2 carcinomas received a hepatic arterial infusion of ferromagnetic particles suspended in lipiodol. Four rabbits were sacrificed after 60 min to determine the acute tissue response, and the other four rabbits were sacrificed after 14 days to determine the longer-term tissue response. The tumour, normal hepatic parenchyma (NHP), lungs and gallbladder of each subject were examined using light microscopy, and chemically analysed for iron concentration. Large aggregates of particles embolized within the tumour vasculature. There was only a sparse distribution of particles in the NHP, with no acute tissue response. The tumour to NHP iron concentration ratio was 4.9. Particles also lodged in blood vessels of the gallbladder wall. Two weeks after infusion there were isolated foci of necrosis in the NHP, and macrophages were associated with particle aggregates, which were also observed within multinucleated giant cells. There was no evidence that particles embolized in the lungs. Hepatic arterial infusion of ferromagnetic particles suspended in lipiodol resulted in excellent tumour targeting with no acute tissue reaction in the NHP, and no evidence of pulmonary embolization. After 14 days there was evidence of phagocytosis of the particles in NHP, but not in the tumour tissue. However, the suspension caused multiple foci of infarction in NHP, probably due to occlusion of larger arteries.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680709     DOI: 10.1023/a:1022555431476

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  6 in total

1.  Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography.

Authors:  Hui-Ming Yi; Bao-Huan Cai; Xi Ai; Kai-Yan Li; Wei Zhang
Journal:  Curr Med Sci       Date:  2019-10-14

2.  Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features.

Authors:  Jun-Hui Sun; Yue-Lin Zhang; Chun-Hui Nie; Xiao-Bo Yu; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

3.  Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy.

Authors:  Kwang-Hun Lee; Eleni Liapi; Josephina A Vossen; Manon Buijs; Veronica Prieto Ventura; Christos Georgiades; Kelvin Hong; Ihab Kamel; Michael S Torbenson; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2008-08-27       Impact factor: 3.464

4.  Complex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potential.

Authors:  Akinaga Sonoda; Norihisa Nitta; Ayumi Nitta-Seko; Shinich Ohta; Shigeyuki Takamatsu; Yoshio Ikehata; Isamu Nagano; Jun-ichiro Jo; Yasuhiko Tabata; Masashi Takahashi; Osamu Matsui; Kiyoshi Murata
Journal:  Int J Nanomedicine       Date:  2010-08-09

5.  Study of the intra-arterial distribution of Fe₃O₄ nanoparticles in a model of colorectal neoplasm induced in rat liver by MRI and spectrometry.

Authors:  José J Echevarria-Uraga; Ignacio García-Alonso; Fernando Plazaola; Maite Insausti; Néstor Etxebarria; Alberto Saiz-López; Begoña Fernández-Ruanova
Journal:  Int J Nanomedicine       Date:  2012-05-09

Review 6.  Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research.

Authors:  Yi-Xiang J Wang; Shouhu Xuan; Marc Port; Jean-Marc Idee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.